Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of dual inhibition of renin-angiotensin-aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits.

Literature DB >> 31865522

Effects of dual inhibition of renin-angiotensin-aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits.

Giuliano Tocci^1,2, Barbara Citoni¹, Vivianne Presta¹, Giovanna Leoncini^3,4, Francesca Viazzi^3,4, Barbara Bonino^3,4, Massimo Volpe^1,2, Roberto Pontremoli^5,6.

Abstract

Chronic kidney disease is a worldwide health problem often burdened by severe cardiovascular complications. Hypertension represents one of the most important risk factor in affecting cardiovascular profile of chronic kidney disease patients. Since renin-angiotensin-aldosterone system plays a major role in determining cardiovascular outcome, guidelines recommend the use of renin-angiotensin-aldosteron inhibitors in order to control hypertension.

Entities: Chemical Disease Gene Species

Keywords: Cardiovascular risk; Hypertension; Renin-angiotensin-aldosterone

Year: 2019 PMID： 31865522 DOI： 10.1007/s11739-019-02257-3

Source DB: PubMed Journal: Intern Emerg Med ISSN： 1828-0447 Impact factor: 3.397

48 in total

Review 1. Direct renin inhibition: from pharmacological innovation to novel therapeutic opportunities.

Authors: Massimo Volpe; Roberto Pontremoli; Claudio Borghi
Journal: High Blood Press Cardiovasc Prev Date: 2011-09-01

2. Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: Insights from the EUROASPIRE IV survey of the European Society of Cardiology.

Authors: Martin Wagner; Christoph Wanner; Kornelia Kotseva; David Wood; Dirk De Bacquer; Lars Rydén; Stefan Störk; Peter U Heuschmann
Journal: Eur J Prev Cardiol Date: 2017-05-15 Impact factor: 7.804

Review 3. Hypertension in chronic kidney disease and dialysis: pathophysiology and management.

Authors: Rajiv Agarwal
Journal: Cardiol Clin Date: 2005-08 Impact factor: 2.213

Review 4. Renin-angiotensin-aldosterone system blockade in chronic kidney disease: current strategies and a look ahead.

Authors: Francesca Viazzi; Barbara Bonino; Francesca Cappadona; Roberto Pontremoli
Journal: Intern Emerg Med Date: 2016-03-17 Impact factor: 3.397

Review 5. Antihypertensive agents for preventing diabetic kidney disease.

Authors: Jicheng Lv; Vlado Perkovic; Celine V Foote; Maria E Craig; Jonathan C Craig; Giovanni F M Strippoli
Journal: Cochrane Database Syst Rev Date: 2012-12-12

Review 6. Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis.

Authors: Hiddo J Lambers Heerspink; Tobias F Kröpelin; Jarno Hoekman; Dick de Zeeuw
Journal: J Am Soc Nephrol Date: 2014-11-24 Impact factor: 10.121

7. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension.

Authors: G Cerasola; S Cottone; G Mulé; E Nardi; M T Mangano; G Andronico; A Contorno; M Li Vecchi; P Galione; F Renda; G Piazza; V Volpe; A Lisi; L Ferrara; N Panepinto; R Riccobene
Journal: J Hypertens Date: 1996-07 Impact factor: 4.844

8. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

Authors: Johannes F E Mann; Roland E Schmieder; Matthew McQueen; Leanne Dyal; Helmut Schumacher; Janice Pogue; Xingyu Wang; Aldo Maggioni; Andrzej Budaj; Suphachai Chaithiraphan; Kenneth Dickstein; Matyas Keltai; Kaj Metsärinne; Ali Oto; Alexander Parkhomenko; Leopoldo S Piegas; Tage L Svendsen; Koon K Teo; Salim Yusuf
Journal: Lancet Date: 2008-08-16 Impact factor: 79.321

9. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study.

Authors: Michael Böhm; Martin Thoenes; Nicolas Danchin; Peter Bramlage; Pablo La Puerta; Massimo Volpe
Journal: J Hypertens Date: 2007-11 Impact factor: 4.844

Review 3. ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients.

Authors: Vivianne Presta; Ilaria Figliuzzi; Barbara Citoni; Giovanna Gallo; Allegra Battistoni; Giuliano Tocci; Massimo Volpe
Journal: High Blood Press Cardiovasc Prev Date: 2021-03-12

3 in total